According to the latest report published by Credence Research, Inc. “Ablation Devices Market By Devices (Generators, Catheters And Probes, Disposables And Accessories), By Energy (Electrical, Radiofrequency, Cryoablation, Radiation, Laser, Ultrasound, Microwave, Hydrothermal), By Applications (Tumor Management, General Surgery, Cardiology (Cardiac Rhythm Management And Hypertension Treatment), Pain Management, Aesthetics, Gynecology) – Growth, Share, Opportunities & Competitive Analysis, 2016 – 2023,” the global ablation devices market was valued at USD10.6 Bn in 2015, and is expected to reach USD21.3 Bn by 2023, expanding at a CAGR of 9% from 2016 to 2023.
Ablation is a minimally invasive therapeutic procedure used for destruction and dissection ofdiseased tissue. Ablation is commonly used for treatment of conditions such as cancer, ophthalmic disorders urologic diseases, gynecological conditions and orthopedic disorders. Based on device type, this report categorizes ablation devices market into generators, catheters and probes, and disposables and accessories. Generators due to their higher prices and augmenting installation base is the largest device segment in the market.
Browse the full report at https://www.credenceresearch.com/report/ablation-devices-market
The overall ablation devices market is technologically driven. Other major drivers of this market are growing incidence of chronic target diseases such as cancer and CVD, technological advancements, growing demand for minimally invasive procedures, and rapid growth in the pool of high-risk geriatric population. Conversely, stringent approval requirements and high cost of equipment are the major set of challenges faced towards the market progression. Ablation devices market is highly competitive with existence of a multitude of players closely competing to augment their foothold in the market.
Among the energy types used for delivering ablation, radiofrequency is the most sought technology and has the highest number of products commercially available. Other key segments include ultrasound ablation, laser ablation and electrical ablation. High safety of RF ablation is the key factor contributing to the dominance of RF ablation devices in the global market. However, with the emergence of novel technologies such as cryoablation and microwave ablation, the demand for RF ablation will experience a slight competition, yet not a complete upset in the overall market situation. The growth of microwave ablation segment is high primarily due to high successful treatment outcomes in cancer and efficiency in producing larger ablation zones as against RF ablation.
Ablation devices are widely used in cardiovascular applications, and their demand in cardiology is anticipated to further grow during the forecast period. Domination of this segment is due to perpetual growth in incidence of cardiovascular diseases such as atrial fibrillation worldwide and introduction of novel ablation techniques for atrial fibrillation treatment. North America and Europe together are the largest regional markets for ablation devices. Favorable reimbursement scenario, early product introductions, better awareness and high incidence of chronic diseases are the key factors that drive the dominance of North America and Europe on the global front. On the other hand, growing government healthcare expenditure, rapid evolution of healthcare infrastructure and proliferation of medical tourism will render the swift market growth in Asia Pacific.
This market is highly competitive and is characterized by presence of several existing players and continuous influx of new market entrants. The existing players are increasingly focusing their growth strategies towards establishing their foothold in emerging markets of Asia Pacific and Middle East and Africa. Key players in the global ablation devices market are but not limited to Medtronic, Inc., St. Jude Medical, Inc., Boston Scientific Corporation, AngioDynamics, Olympus Corporation, Atricure, Smith & Nephew PLC and others.
Download Free PDF Sample Request: https://www.credenceresearch.com/sample-request/58023
Table of Content
Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
Chapter 2 Executive Summary
2.1 Ablation Devices Market, by Devices, 2015 & 2023 (Value %)
2.2 Ablation Devices Market, by Energy Type, 2015 (USD Mn)
2.3 Ablation Devices Market, by Applications, 2015 (USD Mn)
2.4 Ablation Devices Market Share, by Geography, 2015 (Value %)
Chapter 3 Ablation Devices Market: Market Dynamics and Outlook
3.1 Introduction, Facts and Figures
3.5 Market Inclination Insights Assessment
3.6 Attractive Investment Proposition
3.7 Porter’s Five Forces Analysis: Ablation Devices Market
3.8 Competitive Analysis: Ablation Devices Market, by Key Market Players
Chapter 4 Global Ablation Devices Market Analysis, by Devices, 2013-2023 (USD Mn)
4.3 Catheters and Probes
4.4 Disposables and Accessories
Chapter 5 Global Ablation Devices Market Analysis, by Energy Type, 2013-2023 (USD Mn)
Chapter 6 Global Ablation Devices Market Analysis, by Applications, 2013-2023 (USD Mn)
6.2 Tumor Management
6.3 General Surgery
6.4 Cardiology (Cardiac Rhythm Management and Hypertension Treatment)
6.5 Pain Management
Chapter 7 Global Ablation Devices Market, by Geography, 2013-2023 (USD Mn)
7.2 North America
7.2.1 United States
7.3.1 United Kingdom
7.3.3 Rest of Europe
7.4.3 Rest of Asia Pacific
7.5 Middle East and Africa (MEA)
7.6 Latin America
Chapter 8 Company Profiles
8.1 Medtronic, Inc.
8.2 Boston Scientific Corporation
8.3 St. Jude Medical
8.4 Arthrex, Inc.
8.5 AngioDynamics, Inc.
8.6 Olympus Corporation
8.7 C.R. Bard Inc.
8.8 Smith & Nephew
8.9 Accuray, Inc.
8.10 ConMed Corporation
8.11 Galil Medical, Inc.
8.12 AtriCure, Inc.
8.13 Other Notable Payers
Do Enquiry before Buying for research report: https://www.credenceresearch.com/inquiry-before-buying/58023
Credence Research is a worldwide market research and counseling firm that serves driving organizations, governments, non-legislative associations, and not-for-benefits. We offer our customers some assistance with making enduring enhancements to their execution and understand their most imperative objectives. Over almost a century, we’ve manufactured a firm extraordinarily prepared to this task.
Name: Chris Smith
Address: 105 N 1st ST #429,
SAN JOSE, CA 95103 US
Toll-Free (US/CANADA) Ph.: +1-800-361-8290